Showing 31-40 of 143 results for "".
What’s Growing in Pattern Hair Loss Care?
https://practicaldermatology.com/topics/hair-nails/whats-growing-in-pattern-hair-loss-care/23934/Peter Panagotacos, MD, provides expert advice for surgical and nonsurgical options for treating androgenetic alopecia.Hype v. Hope: Cannabinoids in Dermatology
https://practicaldermatology.com/topics/psoriasis/hype-v-hope-cannabinoids-in-dermatology/19686/Integrative dermatology is growing, along with interest in the potential use of cannabinoids in dermatology. Peter Lio, MD addresses the science and the limitations of CBD.Expert Panel Consensus on Uniform Nomenclature and Diagnosis for Neuropathic Pruritus
https://practicaldermatology.com/issues/june-2024/expert-panel-consensus-on-uniform-nomenclature-and-diagnosis-for-neuropathic-pruritus/26549/Dr. Peter Lio and colleagues look at a 2023 article working to establish a consensus on uniform nomenclature and diagnosis for neuropathic pruritis.Food and Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/food-and-atopic-dermatitis/19644/Many patients believe certain foods can exacerbate AD. Peter Lio, MD discusses the potential link.New AD Guidelines: A Paradigm Shift in AD Care
https://practicaldermatology.com/programs/practical-dermatology-atopic-dermatitis/new-ad-guidelines-a-paradigm-shift-in-ad-care/24024/Peter Lio, MD, reviews an updated model of clinical guidance in a rapidly changing healthcare environment.Non-Pharmacological Treatments for Skin Picking Disorder
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/non-pharmacological-treatments-for-skin-picking-disorder/33165/Peter Lio, MD, and Isabella Lewin explore a paper about non-pharmalogical options for skin picking disorder.How Does Consideration of the Microbiome Affect Topical Product Selection
https://practicaldermatology.com/topics/atopic-dermatitis/how-does-consideration-of-the-microbiome-affect-topical-product-selection/19827/A healthy microbiome is a hallmark of healthy skin, while dysbiosis is implicated in various dermatologic diseases. Dr. Friedman explains how this knowledge should influence topical skin care.Atopic Dermatitis: The Critical Need for Treatment
https://practicaldermatology.com/topics/atopic-dermatitis/atopic-dermatitis-the-critical-need-for-treatment/19668/The therapeutic landscape for atopic dermatitis is expanding, as is understanding of the disease and its impact. More than ever, patients need access to effective therapies and meaningful symptom control strategies, says Adam J. Friedman, MD.Ask an Expert: What's the Role for Infliximab in HS?
https://practicaldermatology.com/topics/general-topics/ask-an-expert-whats-the-role-for-infliximab-in-hs/19671/Evidence shows that infliximab, with its weight-based dosing, can be effective for hidradenitis suppurative. Steven Cohen, MD discusses the data and practical considerations with host Adam Friedman, MD.Buyer Beware: CBD Products May Peddle False Hope Amid Corona Fears
https://practicaldermatology.com/series/dermatology-dispatches/buyer-beware-cbd-products-may-peddle-false-hope-amid-corona-fears/19775/Any claims that a medical cannabinoid-based product can kill COVID-19 are “absolutely unsubstantiated,” warns Adam Friedman, MD. There is no evidence that these products contain any antiviral properties, and patients should be advised against believing such claims.